SCHEMBL6707464

SCHEMBL6707464

O=C(OCC1C2CCC1NC2)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.45
CHRNA5 P30532 1/20 0.45
CHRNA7 P36544 1/20 0.45
CHRNA4 P43681 1/20 0.45
TDP1 Q9NUW8 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
ATM Q13315 1/20 0.41
CARM1 Q86X55 1/20 0.41
PRMT6 Q96LA8 1/20 0.41
MAPK1 P28482 1/20 0.41
HIF1A Q16665 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41
PPM1B O75688 1/20 0.40
LMNA P02545 1/20 0.40
ALDH1A1 P00352 1/20 0.40
NPC1 O15118 2/20 0.39
CES2 O00748 1/20 0.39
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6709597 0.99 CHRNB2 (0.44) CHRNB2CHRNA5CHRNA7CHRNA4TDP1
SCHEMBL9172397 0.73 PPM1B (0.51) CHRNB2CHRNA5CHRNA7CHRNA4TDP1
SCHEMBL2452177 0.73 PPM1B (0.51) CHRNB2CHRNA5CHRNA7CHRNA4TDP1
SCHEMBL2452175 0.73 PPM1B (0.51) CHRNB2CHRNA5CHRNA7CHRNA4TDP1
SCHEMBL13286850 0.72 PPM1B (0.56) CHRNB2CHRNA5CHRNA7CHRNA4TDP1
SCHEMBL532785 0.72 CARM1 (0.61) CHRNB2CHRNA5CHRNA7CHRNA4TDP1
SCHEMBL8447322 0.72 CARM1 (0.61) CHRNB2CHRNA5CHRNA7CHRNA4TDP1
SCHEMBL9872465 0.71 TDP1 (0.53) CHRNB2CHRNA5CHRNA7CHRNA4TDP1
SCHEMBL9873005 0.71 TDP1 (0.53) CHRNB2CHRNA5CHRNA7CHRNA4TDP1
SCHEMBL6709525 0.70 CHRNB2 (0.55) CHRNB2CHRNA5CHRNA7CHRNA4CARM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110788-A1 Nicotinic acetylcholine receptor ligands MERCK PATENT GMBH (DE) 2004-06-10 US claimed
US-20040110788-A1 Nicotinic acetylcholine receptor ligands MERCK PATENT GMBH (DE) 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110788-A1 Nicotinic acetylcholine receptor ligands CHRNA1, CHRNA2, CHRNA10 CHRNB2 11/4885CHRNA5 4/4885CHRNA7 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.